Conference
3096 First-line monotherapy with nivolumab (NIVO) in advanced non-small cell lung cancer (NSCLC): Safety, efficacy, and biomarker analyses
Authors
Gettinger SN; Hellmann MD; Shepherd FA; Antonia SJ; Brahmer J; Chow LQ; Goldman J; Juergens R; Borghaei H; Ready NE
Volume
51
Publisher
Elsevier
Publication Date
September 2015
DOI
10.1016/s0959-8049(16)31737-3
Conference proceedings
European Journal of Cancer
ISSN
0959-8049